BNP Paribas Funds Health Care Innovators Privilege Capitalisation
LU0823417224
BNP Paribas Funds Health Care Innovators Privilege Capitalisation/ LU0823417224 /
NAV16/05/2024 |
Diferencia-2.5000 |
Tipo de beneficio |
Enfoque de la inversión |
Sociedad de fondos |
369.2200EUR |
-0.67% |
reinvestment |
Equity
Worldwide
|
BNP PARIBAS AM (LU) ▶ |
Estrategia de inversión
The Fund is actively managed and as such may invest in securities that are not included in the index which is MSCI World Health Care 10/40 (NR). The Benchmark is used for performance comparison only. The Fund is not benchmark constrained and its performance may derivate significantly from that of the benchmark.
The Fund seeks to increase the value of its assets over the medium term by investing in shares issued worldwide by companies which innovate or benefit from healthcare innovation including but not limited to advances in genetic sequencing, drug delivery, miniaturization, bio-compatible materials, haptics and information technology in the healthcare field. Environmental, social and governance (ESG) criteria contribute to, but are not a determining factor in, the manager's decision making.
Objetivo de inversión
The Fund is actively managed and as such may invest in securities that are not included in the index which is MSCI World Health Care 10/40 (NR). The Benchmark is used for performance comparison only. The Fund is not benchmark constrained and its performance may derivate significantly from that of the benchmark.
Datos maestros
Tipo de beneficio: |
reinvestment |
Categoría de fondos: |
Equity |
Región: |
Worldwide |
Sucursal: |
Sector Health / Pharma |
Punto de referencia: |
MSCI World Health Care 10/40 NR |
Inicio del año fiscal: |
01/01 |
Última distribución: |
- |
Banco depositario: |
Bnp Paribas Securities Services Lux. |
País de origen: |
Luxembourg |
Permiso de distribución: |
Austria, Germany, Switzerland, United Kingdom |
Gestor de fondo: |
Jon Stephenson |
Volumen de fondo: |
1.66 mil millones
EUR
|
Fecha de fundación: |
17/05/2013 |
Enfoque de la inversión: |
- |
Condiciones
Recargo de emisión: |
3.00% |
Max. Comisión de administración: |
0.75% |
Inversión mínima: |
3,000,000.00 EUR |
Deposit fees: |
- |
Cargo por amortización: |
0.00% |
Prospecto simplificado: |
Descargar (Versión para imprimir) |
Sociedad de fondos
Fondos de empresa: |
BNP PARIBAS AM (LU) |
Dirección: |
10, rue Edward Steichen, 2540, Luxemburg |
País: |
Luxembourg |
Internet: |
www.bnpparibas-am.com
|
Países
United States of America |
|
70.21% |
United Kingdom |
|
8.11% |
France |
|
5.15% |
Denmark |
|
4.70% |
Switzerland |
|
2.88% |
Ireland |
|
2.68% |
Japan |
|
2.49% |
Belgium |
|
2.27% |
Cash |
|
0.90% |
Canada |
|
0.61% |
Sucursales
Pharma/Biotechnology |
|
57.50% |
Healthcare appliances |
|
22.27% |
Healthcare services |
|
19.33% |
Cash |
|
0.90% |